MX9101861A - Novedosos 2-sacarinilmetil ari carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodo para usarlos - Google Patents

Novedosos 2-sacarinilmetil ari carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodo para usarlos

Info

Publication number
MX9101861A
MX9101861A MX9101861A MX9101861A MX9101861A MX 9101861 A MX9101861 A MX 9101861A MX 9101861 A MX9101861 A MX 9101861A MX 9101861 A MX9101861 A MX 9101861A MX 9101861 A MX9101861 A MX 9101861A
Authority
MX
Mexico
Prior art keywords
ari
compositions
novel
proteolytic enzyme
enzyme inhibitors
Prior art date
Application number
MX9101861A
Other languages
English (en)
Spanish (es)
Inventor
Richard Paul Dunlap
Neil Warren Boaz
Albert Joseph Mura
Virendra Kumar
Dennis John Hlasta
Malcolm Rice Bell
John Joseph Court
Chakrapani Subramanyam
Rajit Chimanlal Desai
Manohar Saindame
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of MX9101861A publication Critical patent/MX9101861A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MX9101861A 1990-11-01 1991-10-30 Novedosos 2-sacarinilmetil ari carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodo para usarlos MX9101861A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60806890A 1990-11-01 1990-11-01

Publications (1)

Publication Number Publication Date
MX9101861A true MX9101861A (es) 1992-07-08

Family

ID=24434891

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101861A MX9101861A (es) 1990-11-01 1991-10-30 Novedosos 2-sacarinilmetil ari carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodo para usarlos

Country Status (17)

Country Link
EP (1) EP0483928A1 (enExample)
JP (1) JPH04273866A (enExample)
KR (1) KR920009807A (enExample)
AU (1) AU642537B2 (enExample)
CA (1) CA2054653A1 (enExample)
FI (1) FI103112B1 (enExample)
HU (2) HUT63399A (enExample)
IE (1) IE913827A1 (enExample)
IL (1) IL99913A (enExample)
MX (1) MX9101861A (enExample)
MY (1) MY131053A (enExample)
NO (1) NO300373B1 (enExample)
NZ (1) NZ240444A (enExample)
PT (1) PT99411B (enExample)
RU (1) RU2114843C1 (enExample)
SG (1) SG69977A1 (enExample)
TW (1) TW221294B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0471756T3 (da) * 1989-05-04 1998-05-18 Sanofi Sa Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW282463B (enExample) * 1991-11-15 1996-08-01 Sterling Winthrop Inc
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (enExample) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
DE19533643A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue cyclische Derivate von Benzolsulfonamiden
TWI462745B (zh) * 2005-04-28 2014-12-01 Takeda Pharmaceutical 安定的乳化組成物
JP6239458B2 (ja) * 2014-07-22 2017-11-29 日本曹達株式会社 2−(ベンジルスルフィニル)−1−シクロアルケン−1−カルボン酸エステルの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US4783473A (en) * 1987-09-02 1988-11-08 E. R. Squibb & Sons, Inc. Geminally substituted cyclic ether carboxylic acids, derivatives thereof, compositions containing same and method of use
DK0471756T3 (da) * 1989-05-04 1998-05-18 Sanofi Sa Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf

Also Published As

Publication number Publication date
TW221294B (enExample) 1994-02-21
HU211929A9 (en) 1996-01-29
PT99411B (pt) 1999-04-30
AU642537B2 (en) 1993-10-21
JPH04273866A (ja) 1992-09-30
KR920009807A (ko) 1992-06-25
AU8608391A (en) 1992-05-07
IL99913A0 (en) 1992-08-18
FI915163A7 (fi) 1992-05-02
PT99411A (pt) 1992-10-30
CA2054653A1 (en) 1992-05-02
EP0483928A1 (en) 1992-05-06
SG69977A1 (en) 2000-01-25
MY131053A (en) 2007-07-31
IL99913A (en) 1996-11-14
RU2114843C1 (ru) 1998-07-10
NO300373B1 (no) 1997-05-20
FI103112B (fi) 1999-04-30
NO914288D0 (no) 1991-11-01
NO914288L (no) 1992-05-04
FI103112B1 (fi) 1999-04-30
HUT63399A (en) 1993-08-30
FI915163A0 (fi) 1991-11-01
IE913827A1 (en) 1992-05-22
NZ240444A (en) 1994-06-27
HU913430D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
MX9101861A (es) Novedosos 2-sacarinilmetil ari carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodo para usarlos
FI971104L (fi) Menetelmä COX-inhibiittoreina käyttökelpoisten fenyyliheterosyklien valmistamiseksi
DE69535721D1 (de) Verfahren zur Verbesserung von der Löslichkeit von pflanzlichen Proteinen
DK478684D0 (da) Enzyminhibitorer
FI965019A7 (fi) Entsyymi-inhibiittoreita
DE69325396D1 (de) Sicherungsring für entfernplattenzusammensetzung
FI950650L (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia hydroksietyyliaminosulfoniamideja
FI950651L (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia sulfonyylialkanoyyliaminohydroksietyyliaminosulfoniamideja
DE69526085D1 (de) Verfahren zur vermeidung von staub
DE3775348D1 (de) Befestigungsmittel und verfahren zum anbringen desselben an plattenfoermiges material.
MX9203520A (es) Inhibidores de proteasa de serina y metodos para aislar los mismos.
MX9207274A (es) Novedosos 2-sacarinilmetil aril y ariloxi acetatos utiles como inhibidores de enzimas proteoliticas y composiciones y metodo de uso de los mismos.
FI903104A0 (fi) Analogiamenetelmä asetyylikoliiniesteraasi-inhibiittoreina käyttökelpoisten yhdisteiden valmistamiseksi
DE59807142D1 (de) Verfahren zur reinigung von anlagenteilen
FI922409A7 (fi) Menetelmä soluviljelyä varten
NO954854D0 (no) Kulturmedietilsetningsstoffer for bioreaktorer
FI20000553L (fi) Proteaasi-inhibiittoreina käyttökelpoisten 4-hydroksi-2-oksopyraanijohdannaisten valmistusmenetelmä
DE3764658D1 (de) Zusammensetzung und verfahren zur verminderung der acetaldehyd-toxicitaet.
KR880700725A (ko) 몰드세척 방법 및 몰드세척용 조성물품
DK0422975T3 (da) Alfa-Glucosidase-inhibitorer
FI960206A7 (fi) Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi
FI960184L (fi) Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi
FI915164A7 (fi) Parannettu menetelmä asetaminofeenin puhdistamiseksi
DE69802204D1 (de) Verfahren zur verbesserung der enzymeaktivität
MX9100121A (es) Inhibidores de proteasas asparticas

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees